Induced Pluripotent Stem Cell Core Facility
Company

Induced Pluripotent Stem Cell Core Facility

Biotechnology Research Montpellier, Hérault, Fr 6 employees
Employees
6

Induced Pluripotent Stem Cell Core Facility Overview

Headquarters
Montpellier, Hérault, Fr
Industry
Biotechnology Research
Employees
6
Founded
2001
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Induced Pluripotent Stem Cell Core Facility

Human induced-pluripotent stem (iPS) cells are produced in order to model in a culture dish any monogenic disorders. iPSC technology is a promising breakthrough in regenerative medicine and it was first pioneered by Yamanaka in 2006. By reprogramming somatic cells like fibroblasts and blood cells, iPSC can be generated directly. The SAFE-iPSC facility provides customers with iPSC lines with high viability that can be generated from different cell sources . https://www.chu-montpellier.fr/fr/plateformes-recherche/safe-ips

Compare Similar Companies to Induced Pluripotent Stem Cell Core Facility